Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents

Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
No abstract available

Keywords: COVID-19; EZH2; SARS-Cov-2; epigenetics; polycomb.

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / metabolism*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / metabolism
  • Drug Delivery Systems*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / metabolism
  • Polycomb-Group Proteins / antagonists & inhibitors*
  • Polycomb-Group Proteins / metabolism
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Polycomb-Group Proteins